Summit X, LLC Gilead Sciences, Inc. Transaction History

Summit X, LLC

$438 Million
Q2 2024

A detailed history of Summit X, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Summit X, LLC holds 23,507 shares of GILD stock, worth $1.85 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

23,507

Previous 21,825 7.71%

Holding current value

$1.85 Million

Previous $1.6 Million 0.88%

% of portfolio

0.37%

Previous 0.42%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $106,218 - $122,584	1,682 Added 7.71%	23,507 $1.61 Million
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $112,452 - $137,132	1,571 Added 7.76%	21,825 $1.6 Million
Q4 2023 Feb 08, 2024	SELL	$73.27 - $83.09 $31,286 - $35,479	-427 Reduced 2.06%	20,254 $1.64 Million
Q3 2023 Nov 03, 2023	SELL	$73.94 - $80.67 $241,192 - $263,145	-3,262 Reduced 13.62%	20,681 $1.55 Million
Q2 2023 Aug 09, 2023	BUY	$76.01 - $86.7 $100,105 - $114,183	1,317 Added 5.82%	23,943 $1.85 Million
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $47,777 - $54,433	618 Added 2.81%	22,626 $1.88 Million
Q4 2022 Feb 02, 2023	SELL	$62.32 - $89.47 $54,156 - $77,749	-869 Reduced 3.8%	22,008 $1.89 Million
Q3 2022 Nov 01, 2022	BUY	$59.54 - $68.01 $51,502 - $58,828	865 Added 3.93%	22,877 $1.41 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $22,453 - $25,288	389 Added 1.8%	22,012 $1.36 Million
Q1 2022 May 05, 2022	BUY	$57.92 - $72.58 $81,145 - $101,684	1,401 Added 6.93%	21,623 $1.29 Million
Q4 2021 Jan 19, 2022	BUY	$64.88 - $73.64 $58,391 - $66,276	900 Added 4.66%	20,222 $1.47 Million
Q3 2021 Oct 19, 2021	BUY	$67.69 - $73.03 $65,523 - $70,693	968 Added 5.27%	19,322 $1.35 Million
Q2 2021 Jul 16, 2021	BUY	$63.47 - $69.35 $20,691 - $22,608	326 Added 1.81%	18,354 $1.27 Million
Q1 2021 May 10, 2021	SELL	$60.0 - $68.46 $401,700 - $458,339	-6,695 Reduced 27.08%	18,028 $1.16 Million
Q4 2020 Jan 29, 2021	SELL	$56.65 - $64.55 $252,942 - $288,215	-4,465 Reduced 15.3%	24,723 $1.44 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $33,471 - $42,085	539 Added 1.88%	29,188 $19.7 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $59,752 - $69,384	826 Added 2.97%	28,649 $2.21 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $734,963 - $941,381	-11,735 Reduced 29.67%	27,823 $2.07 Million
Q4 2019 Jan 23, 2020	BUY	$61.62 - $67.78 $223,680 - $246,041	3,630 Added 10.1%	39,558 $2.57 Million
Q3 2019 Oct 15, 2019	BUY	$62.51 - $69.0 $2.25 Million - $2.48 Million	35,928 New	35,928 $2.28 Million
Q4 2017 Jan 23, 2018	SELL	$71.15 - $83.52 $244,756 - $287,308	-3,440 Closed	0 $0
Q3 2017 Oct 17, 2017	SELL	$72.11 - $85.47 $10,023 - $11,880	-139 Reduced 3.88%	3,440 $277,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,579	3,579 $253,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $98.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit X, LLC with notifications on news.

Account